Injectable PLGA with EE and DSRP
Description: A drug-delivery system of Poly(D,L-lactic-co-glycolic acid) (PLGA) microparticles and organogels containing drospirenone (DRSP) microcrystals combined with ethinyl estradiol (EE) PLGA microparticles and EE poly(butylcyanoacrylate) (PBCA) microcapsules.
Product Details
User: Female
Hormonal: Yes
Delivery Method: Injectable
Duration Type: Long-acting
Active Pharmaceutical Ingredient (API): - ethinyl estradiol
- drospirenone
- ethinyl estradiol
- drospirenone
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Bayer HealthCare
Project Phase: Discovery and Early Development
Development Stage: Prototype Development
Active Development: No
Additional Information
References: Nippe S. (2012) Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release. Eur J Pharm Sci. 47(4):790-800.
Nippe S. (2012) Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release. Eur J Pharm Sci. 47(4):790-800.